Inventor · disambiguated record
Nathan David Pfeifer
Also filed as: PFEIFER NATHAN DAVID
0 granted patents·3 pending applications·0 citations·filing 2021–2023
Technology areasA61K
Files withTHERAVANCE BIOPHARMA R&D IP LLC3
Top patents by PatentIndex Score
3 records- 0162US2025288561A1Nezulcitinib for delivery by nebulized oral inhalationTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Application pending·0 cites
- 0257US2023021647A1Method of treating a patient infected with a coronavirus and having a baseline level of crp below 150 mg/lTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 0352US2021346357A1Method of treating a patient infected with a coronavirus with a dimethyl amino azetidine amide compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nathan David Pfeifer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →